Details for New Drug Application (NDA): 214115
NDA 214115 describes ISOSORBIDE MONONITRATE, which is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Alkermes Gainesville, Aurobindo Pharma, Chartwell Molecular, Dexcel Ltd, Hikma, Ivax Sub Teva Pharms, Riconpharma Llc, Shandong, Skyepharma Ag, Strides Pharma Intl, Torrent Pharms, Zydus Hlthcare, Zydus Pharms, Ani Pharms, and Genus, and is included in twenty NDAs. It is available from twenty-two suppliers. Additional details are available on the ISOSORBIDE MONONITRATE profile page.
The generic ingredient in ISOSORBIDE MONONITRATE is isosorbide mononitrate. There is one drug master file entry for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the isosorbide mononitrate profile page.
The generic ingredient in ISOSORBIDE MONONITRATE is isosorbide mononitrate. There is one drug master file entry for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the isosorbide mononitrate profile page.
Summary for 214115
| Tradename: | ISOSORBIDE MONONITRATE |
| Applicant: | Shandong |
| Ingredient: | isosorbide mononitrate |
| Patents: | 0 |
Pharmacology for NDA: 214115
| Physiological Effect | Vasodilation |
Suppliers and Packaging for NDA: 214115
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 214115 | ANDA | AiPing Pharmaceutical, Inc. | 11788-159 | 11788-159-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (11788-159-01) |
| ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 214115 | ANDA | AiPing Pharmaceutical, Inc. | 11788-159 | 11788-159-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (11788-159-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 120MG | ||||
| Approval Date: | Apr 29, 2022 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 30MG | ||||
| Approval Date: | Feb 8, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 60MG | ||||
| Approval Date: | Feb 8, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
